Holen Sie sich die Stockscreener-App
0.9261
10.61%
0.0894
Schlusskurs vom Vortag:
$0.8367
Offen:
$0.84
24-Stunden-Volumen:
557.85K
Relative Volume:
0.74
Marktkapitalisierung:
$247.27M
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
6.174
EPS:
0.15
Netto-Cashflow:
$-68.47M
1W Leistung:
+4.83%
1M Leistung:
-0.18%
6M Leistung:
-33.42%
1J Leistung:
-16.24%
1-Tages-Spanne:
$0.8317
$0.93
1-Wochen-Bereich:
$0.7739
$0.93
52-Wochen-Spanne:
$0.7739
$1.93
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Vergleichen Sie PGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PGEN | 0.9257 | 247.27M | 6.23M | -95.90M | -68.47M | 0.15 |
| VRTX | 449.47 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.65 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.07 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.16 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.06 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Insiders Sold Precigen Prematurely At US$1.41 With Stock Trading Higher - Simply Wall St
Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86% - Yahoo Finance
Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reduces Earnings Estimates for Precigen - MarketBeat
PGEN stock touches 52-week low at $0.78 amid market challenges - Investing.com Canada
HC Wainwright Reiterates Buy Rating for Precigen (NASDAQ:PGEN) - MarketBeat
Precigen Inc. (PGEN) Quarterly 10-Q Report - Quartzy
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Precigen Inc (PGEN) Q3 2024 Earnings: EPS Misses at $(0.09), Rev - GuruFocus.com
Precigen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Precigen earnings missed, revenue fell short of estimates By Investing.com - Investing.com UK
Precigen Reports Third Quarter 2024 Financial Results and Business Updates - Quantisnow
Precigen (NASDAQ:PGEN) Shares Cross Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Precigen CEO to Present at Stifel 2024 Healthcare Conference: Gene Therapy Innovation Spotlight | PGEN Stock News - StockTitan
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Target Price from Analysts - MarketBeat
PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com
Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com
Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com
High Growth Tech Stocks To Watch In October 2024 - Simply Wall St
Should you Hold Precigen (PGEN)? - Insider Monkey
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily
Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia
Precigen Inc (PGEN) stock analysis: A simple moving average approach - US Post News
Precigen reclaims rights after terminating license agreement - Investing.com India
Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch
Precigen Regains Full Control of Technology Post Agreement Termination - TipRanks
Precigen : Termination of Material Agreement Form 8 K - Marketscreener.com
Upward Trajectory: Precigen Inc (PGEN) Posts a Slidee, Closing at 0.85 - The Dwinnex
When Will Precigen, Inc. (NASDAQ:PGEN) Turn A Profit? - Simply Wall St
PGEN stock touches 52-week low at $0.83 amid market challenges - Investing.com
PGEN’s latest rating updates from top analysts. - Knox Daily
Is Precigen Inc (PGEN) positioned for future growth? - SETE News
SVP, IP Affairs Perez Jeffrey Thomas acquire 58,823 shares of Precigen Inc [PGEN] - Knox Daily
How to interpret Precigen Inc (PGEN)’s stock chart patterns - US Post News
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Financial Analysis: Precigen Inc (PGEN)’s Ratios Unveil Key Insights - The Dwinnex
Precigen Inc (PGEN) receives an Underweight rating from JP Morgan - Knox Daily
Precigen's SWOT analysis: biotech firm's stock rides on PRGN-2012 success - Investing.com
Precigen Inc (PGEN)’s stock performance: a year in review - US Post News
Biotech Co. Precigen Announces IP Exec's Departure - Law360
Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Precigen senior VP Jeffrey Perez quits - Investing.com
J.P. Morgan cuts Precigen to underweight, cites burn rate - MSN
Precigen Inc Inc. (PGEN) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Precigen Inc [NASDAQ: PGEN] Sees Increase in Stock Value - Knox Daily
What is Precigen Inc (PGEN) Stock Return on Shareholders’ Capital? - SETE News
Investing in Precigen Inc (PGEN): What You Must Know - Knox Daily
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):